FIELD: medicine.
SUBSTANCE: invention relates to biochemistry, particularly to a polypeptide capable of inducing a specific immune response against Borrelia bacteria, and a polynucleotide encoding it. Also disclosed are an expression vector comprising said polynucleotide, a host cell containing it and a method of producing a peptide by culturing said host cell. Invention also relates to compositions comprising said polynucleotides or polypeptides for inducing a specific immune response against Borrelia bacteria.
EFFECT: invention enables to effectively treat or prevent Borrelia infection or Lyme disease.
24 cl, 24 dwg, 9 tbl, 22 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CHIMERIC OSPA GENES, PROTEINS AND THEIR APPLICATION METHODS | 2011 |
|
RU2773402C2 |
| OspA CHIMERIC GENES, PROTEINS, AND METHODS FOR THEIR USE | 2011 |
|
RU2636455C2 |
| VACCINE AGAINST LYME DISEASE IN DOGS | 2018 |
|
RU2785620C2 |
| RECOMBINANT CHIMERIC POLYPEPTIDES, CARRYING EPITOPES OF VARIOUS IMMUNODOMINANT PROTEINS OF SPIROCHAETA OF BORRELIA BURGDORFERI SENSU LATO COMPLEX, AND SERUM DIAGNOSTIC TECHNIQUE FOR IXODIC TICK-BORNE BORRELIOSIS | 2012 |
|
RU2514230C1 |
| COMPOSITIONS CONTAINING THREE FUSED OSPA PROTEINS FOR USE IN MEDICINE | 2021 |
|
RU2837669C1 |
| DNA ANTIBODY CONSTRUCTIONS FOR USE AGAINST LYME DISEASE | 2017 |
|
RU2813829C2 |
| ANTIGENIC POLYPEPTIDES BASED ON OSPA SEQUENCE | 2019 |
|
RU2816208C2 |
| BORRELIA HYBRID PROTEIN, NUCLEIC ACID CODING THIS PROTEIN, EXPRESSING CARTRIDGE, VECTOR, METHOD AND KIT FOR DIAGNOSING LYME BORRELIOSIS, VACCINE FOR BORRELIOSIS PREVENTION | 2010 |
|
RU2549698C2 |
| DOG LYME BORRELIOSIS VACCINE | 2007 |
|
RU2460538C2 |
| INFLUENZA HAEMAGGLUTININ AND NEURAMINIDASE VARIANTS | 2010 |
|
RU2535970C2 |
